XML 51 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes (as restated) (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
Earnings (loss) before income taxes from continuing operations consists of the following:
December 31 2020
(as restated)
December 31, 2019December 31, 2018
United States$(373.2)$(201.1)$(351.4)
Non-U.S. (1)
118.6 96.8 80.4 
Total loss before income taxes$(254.6)$(104.3)$(271.0)

(1)Certain of the Company's Non-U.S. entities generate significant losses for which a valuation allowance is provided for and accordingly do not create a tax benefit.
Schedule of Components of Income Tax Expense (Benefit) The principal components of income tax expense (benefit) from continuing operations consists of the following:
December 31, 2020December 31, 2019December 31, 2018
Current:
Federal$0.1 $— $— 
State and local0.6 (1.4)6.0 
Non-U.S.73.4 51.0 83.8 
Deferred:
Federal2.3 (0.4)(8.4)
State and local2.9 (1.8)(2.7)
Non-U.S.(6.6)(10.9)(28.8)
Income tax expense (benefit)$72.7 $36.5 $49.9 
Schedule of Effective Income Tax Rate Reconciliation
Reconciliation of U.S. federal statutory taxes to the Company’s total income tax expense (benefit) from continuing operations consists of the following:
December 31, 2020
(as restated)
December 31, 2019December 31, 2018
Taxes at U.S. statutory rate (21%)
$(53.5)$(21.9)$(56.9)
State and local taxes, net of federal tax benefit(4.9)(4.0)(6.0)
Non-U.S. rate differential4.6 4.3 4.2 
Non-U.S. tax holidays(9.2)(4.6)(1.8)
Uncertain tax positions16.4 16.0 21.5 
Tax Cuts and Jobs Act of 2017— — (14.1)
Global intangible low-tax income inclusion15.4 13.8 4.2 
Change in valuation allowances82.1 17.0 104.7 
Taxes on undistributed foreign earnings and withholding/ dividend taxes9.8 8.5 (2.3)
U.S. implications of non-U.S. earnings(2.6)(1.8)12.3 
R&D deduction/ credit(7.9)(2.2)(11.8)
Non-taxable settlement of contingent consideration— — (3.2)
Change in fair value of warrant liabilities30.2   
Other permanent differences4.9 6.7 10.5 
Impact of rate changes in non-U.S. jurisdictions(2.6)4.8 (1.3)
Outside basis difference on divestiture— — (6.6)
Impact of transaction costs(4.8)— — 
Other (1)
(5.2)(0.1)(3.5)
Total income tax expense (benefit)$72.7 $36.5 $49.9 

(1)Represents several adjustments, none of which are significant for separate disclosure.
Schedule of Deferred Tax Assets and Liabilities The principal items that gave rise to deferred income tax assets and liabilities follow:
December 31, 2020December 31, 2019
Deferred tax assets
Net operating losses and capital losses$156.0 $131.7 
Accrued liabilities44.9 30.0 
Employee compensation and benefits10.1 13.7 
Pensions14.8 13.3 
Business interest deduction limitation80.7 98.9 
Inventory21.8 20.4 
R&D credit carryforward8.8 6.6 
Lease liability13.7 19.8 
Bad debts7.5 6.3 
Foreign tax credit carryforward7.6 — 
Other0.4 0.3 
Total deferred tax assets, before valuation allowances$366.3 $341.0 
Valuation allowances$(274.7)$(205.7)
Deferred tax assets, net of valuation allowances$91.6 $135.3 
Deferred tax liabilities
Intangibles & Goodwill(95.5)(106.9)
Undistributed foreign earnings(38.0)(45.1)
Property, plant & equipment(30.6)(31.2)
Debt issuance costs(3.2)(46.1)
Lease Right of Use Asset(12.1)(18.8)
Other(7.8)(2.9)
Total deferred tax liabilities$(187.2)$(251.0)
Net deferred income tax liabilities$(95.6)$(115.7)
Schedule of Unrecognized Tax Benefits Roll Forward Following are changes in unrecognized tax benefits before considering recoverability of cross-jurisdictional tax credits (federal, state, and non-U.S.) and temporary differences. The amount of unrecognized tax benefits is not expected to significantly increase or decrease within the next 12 months.
December 31, 2020December 31, 2019December 31, 2018
Beginning balance$52.6 $38.4 $22.0 
Additions for the current year tax positions13.2 10.2 11.6 
Additions for prior year tax positions8.1 5.5 9.6 
Reductions for prior year tax positions(1.5)(1.0)(4.8)
Reductions for settlements with tax authorities— — — 
Reductions for expirations of statute of limitations(2.4)(0.5)— 
Ending balance$70.0 $52.6 $38.4